In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 1127 for your search:
Cancer Type/Condition:  childhood cancer
Stage/Subtype:  childhood cancer
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV, Phase III
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: GPOH-NB2004, EU-20661, NCT00410631
2.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 1 to 18
Sponsor: Other
Protocol IDs: UKALL2003, NCT00222612
3.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 1 to 14
Sponsor: Other
Protocol IDs: 2005-000658-56, 20040177, 2004-41-4276, NCT00192673
4.

Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: 6 months to 21 years
Sponsor: Other
Protocol IDs: SHEBA-06-4013-IK-CTIL, NCT00339118
5.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: 102010, 2006-003260-53, NCT00357942
6.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 60
Sponsor: Other
Protocol IDs: Hemato INCAN 01/2007, NCT00429065
7.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and under
Sponsor: NICHD
Protocol IDs: PPRU 10762, NCT00491946
8.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 and under
Sponsor: Other
Protocol IDs: LAL-BR/2001, NCT00526175
9.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 16 and under
Sponsor: Other
Protocol IDs: LAL-AR-N-2005, NCT00526409
10.

Phase: Phase IV
Type: Diagnostic, Supportive care
Status: Active
Age: 16 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CICL670AAU01, NCT00673608
11.

Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 4 to 14
Sponsor: Other
Protocol IDs: CAAE0450020300008, NCT00808171
12.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: SCT 0208, NCT00679536
13.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 16 and under
Sponsor: Other
Protocol IDs: 2007016, NCT00846703
14.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: PETHEMA-LAM07, NCT01041040
15.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 17 and under
Sponsor: Other
Protocol IDs: CDR0000667369, EURONET-PHL-LP1, EUDRACT-2007-004092-19, EU-21011, NCT01088750
16.

Phase: Phase IV
Type: Health services research, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UKM-SF-042010, NCT01114165
17.

Phase: Phase IV
Type: Health services research, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SCH-2010-04, NCT01125865
18.

Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: Par 06-0045, NCT01313247
19.

Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: 21 and under
Sponsor: Other
Protocol IDs: TASMC-11-MB-442-CTIL, NCT01339988
20.

Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: Any age
Sponsor: Other
Protocol IDs: UKM08_0057, 2009-018072-33, NCT01424839
21.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 12 to 70
Sponsor: Other
Protocol IDs: 23-16/11/2001, NCT01438437
22.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 55 and under
Sponsor: Other
Protocol IDs: LAL Ph-2008, NCT01491763
23.

Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: 8 to 70
Sponsor: Other
Protocol IDs: Lithium-5010, NCT01669369
24.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 10 to 90
Sponsor: Other
Protocol IDs: MST/MDS-307PLAH-ASH, NCT01674985
25.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: BfArM 4022064, DKH 50-2728, UCHM-AML-BFM-2004, UCHM-BfArM 4022064, UCHM-DKH 50-2728, EU-20723, AML-BFM 2004, NCT00111345
1     
New Search